Global Trust Asset Management, LLC Gilead Sciences, Inc. Transaction History

Global Trust Asset Management, LLC

$266 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $4,860 - $6,978	-78 Reduced 11.0%	631 $54,000
Q3 2022 Oct 07, 2022	BUY	$59.54 - $68.01 $4,644 - $5,304	78 Added 12.36%	709 $44,000
Q2 2022 Jul 12, 2022	SELL	$57.72 - $65.01 $9,004 - $10,141	-156 Reduced 19.82%	631 $39,000
Q4 2021 Jan 18, 2022	SELL	$64.88 - $73.64 $33,023 - $37,482	-509 Reduced 39.27%	787 $57,000
Q2 2021 Jul 13, 2021	SELL	$63.47 - $69.35 $14,788 - $16,158	-233 Reduced 15.24%	1,296 $89,000
Q1 2021 Apr 14, 2021	SELL	$60.0 - $68.46 $334,380 - $381,527	-5,573 Reduced 78.47%	1,529 $99,000
Q4 2020 Jan 13, 2021	SELL	$56.65 - $64.55 $23,396 - $26,659	-413 Reduced 5.5%	7,102 $414,000
Q2 2020 Jul 08, 2020	SELL	$72.34 - $84.0 $607,583 - $705,516	-8,399 Reduced 52.78%	7,515 $578,000
Q1 2020 Apr 06, 2020	BUY	$62.63 - $80.22 $513,190 - $657,322	8,194 Added 106.14%	15,914 $1.21 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $59,586 - $65,543	-967 Reduced 11.13%	7,720 $502,000
Q3 2019 Oct 15, 2019	SELL	$62.51 - $69.0 $27,441 - $30,291	-439 Reduced 4.81%	8,687 $551,000
Q2 2019 Jul 23, 2019	SELL	$61.87 - $69.38 $17,694 - $19,842	-286 Reduced 3.04%	9,126 $617,000
Q1 2019 Apr 05, 2019	SELL	$62.53 - $70.05 $26,262 - $29,421	-420 Reduced 4.27%	9,412 $612,000
Q4 2018 Jan 11, 2019	SELL	$60.54 - $79.0 $50,248 - $65,570	-830 Reduced 7.78%	9,832 $615,000
Q3 2018 Oct 16, 2018	SELL	$71.28 - $78.92 $119,607 - $132,427	-1,678 Reduced 13.6%	10,662 $823,000
Q2 2018 Jul 18, 2018	SELL	$64.88 - $75.68 $3,892 - $4,540	-60 Reduced 0.48%	12,340 $874,000
Q1 2018 Apr 26, 2018	SELL	$72.84 - $88.8 $9,105 - $11,100	-125 Reduced 1.0%	12,400 $935,000
Q4 2017 Feb 02, 2018	BUY	$71.15 - $83.52 $891,153 - $1.05 Million	12,525	12,525 $897,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Trust Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Trust Asset Management, LLC with notifications on news.

Account